CYP2C19 genetic testing to enhance antiplatelet drug safety and efficacy (MRFF-NHMRC 2024 Genomic Health Futures grant administered by University of Sydney). (2026-2030)
Experts
Associate Professor
Chris Freeman
Clinical Associate Professor
School of Pharmacy and Pharmaceutical Sciences
Faculty of Health, Medicine and Behavioural Sciences
